ACYCLOVIR
- Product NDC
- 67296-0375
- 11-digit product format
- 672960375
- Labeler code
- 67296
- Product ID
- 67296-0375_75712ad2-36fe-4a9d-a722-970e4e594bec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug Inc.
- Application
- ANDA074596
- Marketing category
- ANDA
- Marketing start
- 2009-04-01
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67296-0375-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8827-f424-e053-dadaa90a57ce | Acyclovir tablets |
| 67296-0375-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8827-f424-e053-dadaa90a57ce | Acyclovir tablets |
| 67296-0375-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8827-f424-e053-dadaa90a57ce | Acyclovir tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-0375-1 | ACYCLOVIR | 20 in 1 BOTTLE | TABLET | 20 | 5 | |
| 67296-0375-2 | ACYCLOVIR | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 67296-0375-3 | ACYCLOVIR | 70 in 1 BOTTLE | TABLET | 70 | 5 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Acyclovir | ACTIVE INGREDIENT | X4HES1O11F | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | |
| Acyclovir | ACTIVE MOIETY | X4HES1O11F | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-0375 | ACYCLOVIR TABLET [REDPHARM DRUG INC.] | 5 | Legacy NDC, 3 package rows | 20110808_ffa99978-6b66-49ab-9bd2-8ef6f6846cd7.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197311 | acyclovir 400 MG Oral Tablet | PSN | ffa99978-6b66-49ab-9bd2-8ef6f6846cd7 | 5 |
| 197311 | acyclovir 400 MG Oral Tablet | SCD | ffa99978-6b66-49ab-9bd2-8ef6f6846cd7 | 5 |
| 197311 | acycycloguanosine 400 MG Oral Tablet | SY | ffa99978-6b66-49ab-9bd2-8ef6f6846cd7 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 67296-0375-1 | 67296037501 | 20 in 1 BOTTLE | Historical |
| 67296-0375-2 | 67296037502 | 30 in 1 BOTTLE | Historical |
| 67296-0375-3 | 67296037503 | 70 in 1 BOTTLE | Historical |